Daewoong is leading the development of drug formulation designs using artificial intelligence (AI) technology. The project aims to create an AI-driven platform that can automatically design optimal prescriptions and manufacturing conditions based on target pharmacokinetic data.
Daewoong Develops AI-Driven Drug Formulation Platform
Daewoong will develop an AI-based prescription design platform for controlled-release and multi-component drug formulations as the lead institution of a government-funded project.
Key points
- Daewoong develops AI-driven drug formulation platform
- Collaborates with multiple universities for project
- Aims to create optimal prescriptions using AI
This three-and-a-half-year research will involve collaboration with multiple universities, focusing on developing controlled-release and multi-component formulations. The effectiveness of the platform is expected to be validated in actual drug development processes.
